Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article
Author/s

author: Tapan Kadia  Elias Jabbour  Zeev Estrov  Srdan Verstovsek  Elisa Rumi  Jorge Eduardo Cortes  Francesco Passamonti  Gautam Borthakur  Sherry Pierce  Hagop Kantarjian  Enrica Morra 

Publication date June 20, 2012
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item